INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹95 Cr | ₹155 Cr | ₹179 Cr | ₹174 Cr | ₹82 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹95 Cr |
| Mar2024 | ₹155 Cr |
| Mar2023 | ₹179 Cr |
| Mar2022 | ₹174 Cr |
| Mar2021 | ₹82 Cr |
How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹95 Cr | -38.91 | |
| Mar2024 | ₹155 Cr | -13.11 | |
| Mar2023 | ₹179 Cr | 2.88 | |
| Mar2022 | ₹174 Cr | 111.41 | |
| Mar2021 | ₹82 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,105.4 Cr | -2.3% | -2.6% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.3% |
-2.6% |
-21.7% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses